In an effort to increase access and participation in clinical trials among adult blood cancer patients, The Leukemia & Lymphoma Society (LLS) and Cleveland Clinic Taussig Cancer Institute have launched a groundbreaking partnership, "The Clinical Trial Center for Hematologic Malignancies."

This innovative collaboration is a unique approach to making blood cancer clinical trials available to patients in their community so they can easily have access to the newest treatments for leukemia, lymphoma and myeloma.

LLS, which has set as one of its strategic goals the acceleration of blood cancer therapies by enrolling more people in clinical trials, has access to new therapies and will help determine which drugs should be tested. Cleveland Clinic Taussig Cancer Institute will help to design the trials and administer them. The organizations will co-fund the effort.  Please donate today and help support this effort!

For more information about the clinical trials, please call Taussig's "Cancer Answer Line" at (866) 223-8100 or visit the Cleveland Clinic Taussig Cancer Institute at http://cms.clevelandclinic.org/cancer/.

For more information about local programs in the Cleveland Area, please visit The Leukemia & Lymphoma Society's Northern Ohio Chapter .

back to top